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Abstract
Background: Chronic systemic inflammation and abnormal free fatty acid metabolism are closely related to
ectopic lipid deposition. In this study, we investigate if inflammation tissue-specifically disrupts lipogenesis and
lipolysis in nonadipose tissues and adipose tissue, resulting in ectopic lipid deposition in C57BL/6J mice.
Methods: We used casein injection in C57BL/6J mice to induce a chronic systemic inflammatory stress in vivo.
Serum was analyzed for free fatty acid and cytokines. Insulin sensitivities were evaluated by glucose and insulin
tolerance tests. Liver, muscle, adipose tissues were taken for lipid analysis. Real-time polymerase chain reaction and
western blotting were used to examine the gene and protein expression of molecules involved in adipogenesis
and lipolysis in tissues.
Results: Casein injection elevated serum levels of IL-6 and SAA in mice, which are associated with increased lipid
accumulation in liver and muscle, suggesting that chronic systemic inflammation induces ectopic lipid deposition
in nonadipose tissues. The inflammatory stress upregulated mRNA and protein expression of sterol regulatory
element binding protein 1, fatty acid synthase, and acetyl CoA carboxylase alpha, while inhibited these molecules
expression in adipose. Interestingly, in the same experimental setting, inflammation increased triglyceride lipase
and hormone-sensitive lipase expression in white adipose tissue. Inflammation also induced insulin resistance and
increased serum free fatty acid levels in C57BL/6J mice.
Conclusions: Chronic systemic inflammation increased lipogenesis in nonadipose tissues and lipolysis in white
adipose tissue, resulting in ectopic lipid deposition in nonadipose tissues. This disturbed free fatty acid homeostasis
and caused insulin resistance in C57BL/6J mice.
Keywords: sterol regulatory element binding protein1, fatty acid synthase, acetyl CoA carboxylase, adipose trigly-
ceride lipase
Background
Ectopic lipid deposition which is defined as excess lipids
deposited in nonadipose tissues, mainly in liver and ske-
letal muscle, has been indicated to be a possible major
culprit in development of insulin resistance and is
rapidly becoming a world-wide public health problem
because of the associated development of type 2 diabetes
(T2DM), non-alcoholic fatty liver disease (NAFLD) and
cardiovascular disease [1]. Using magnetic resonance
spectroscopy, it has been demonstrated that increased
intrahepatic lipid content is closely correlated to
impaired hepatic insulin sensitivities in nondiabetic and
diabetic individuals [2,3]. Consistently, in T2DM
patients, insulin requirements are closely related to their
hepatic lipid content [4]. Studies also found that an
increase of intramyocellular lipid content, assessed by
muscle biopsy or magnetic resonance/computed tomo-
graphy, was positively correlated with the development
of muscle insulin resistance and a better predictor of
impaired insulin action than visceral adiposity [5], while
a decrease in intramyocellular lipid content by weight
loss improved insulin sensitivity [6,7].
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animal models, chronic systemic inflammation charac-
terized by the increase of serum levels of C-reactive pro-
tein (CRP) and pro-inflammatory cytokines, such as
tumor necrosis factor alpha (TNF-a), and interleukin-6
(IL-6) is closely related the development of NAFLD,
insulin resistance and other metabolic disorders [8].
Furthermore, in vivo and in vitro studies have demon-
strated that inflammatory cytokines increase serum free
fatty acid (FFA) levels, causing dyslipidemia and NAFLD
which can be prevented by using anti-cytokine antibo-
dies in a mouse model [9,10]. However, the effect of
chronic systemic inflammation on FFA accumulation in
liver and muscle as well as its underlying mechanisms
remains unclear.
Increasing lipogenesis in nonadipose tissues play a
crucial role in ectopic lipid deposition [11]. In mamma-
lian species, lipogenesis of cell is under control of a
family of membrane-bound transcription factors desig-
nated sterol regulatory binding proteins (SREBPs).
SREBPs are members of the basic helix-loophelix leucine
zipper family of transcription factors [12,13], which con-
tain two transmembrane domains and localize in the
endoplasmic reticulum (ER) as a precursor protein after
synthesis. SREBPs on demand are escorted to the Golgi
complex for two sequential cleavages by two proteases,
by which the transcriptional active domains (NH2-
terminal) enter the nucleus and bind to the cognate
sterol-regulatory element (SRE) sites, activating tran-
scription of target genes. Two forms of SREBPs have
been characterized: SREBP1 and SREBP2. Specific ana-
lyses suggest SREBP1 may be selectively involved in acti-
vation of genes in free fatty acid metabolism. SREBP1
regulates the expression of genes encoding rate-limiting
enzymes responsible for de novo lipogenesis, of which
fatty acid synthase (FAS) and acetyl-CoA carboxylase
alpha (ACCa) seems to be particularly important since
their expressions are parallel to the changes of FFA
synthesis rates.
FFA homeostasis of adipocytes is not only dependent
on lipogenesis but also lipolysis. Both adipose triglycer-
ide lipase (ATGL) and hormone-sensitive lipase (HSL)
can initiate triglyceride (TG) degradation by cleaving the
first ester bond. Importantly, ATGL represents the rate-
limiting lipolytic enzyme in mammals, and HSL,
increased by insulin resistance is unique in its capacity
to break down the second ester bond, converting digly-
cerides (DG) to monoglycerides in adipose tissue.
We and other groups demonstrated that chronic sys-
temic inflammation causes cholesterol accumulation in
liver, kidney and vessels by causing cholesterol redistri-
bution and disrupting intracellular cholesterol homeos-
tasis [14]. The current study was undertaken to
investigate if chronic systemic inflammation activated
SREBP1, FAS and ACCa expression in liver and muscle,
and increased ATGL and HSL expression in white adi-
pose tissue, thereby causing ectopic lipid deposition as
well as dyslipidemia and insulin resistance in C57BL/6J
mice.
Methods
Animal Model
Animal care and experimental procedures were per-
formed with approval from the Animal Care Committee
of Chongqing Medical University. Eight week-old
C57BL/6J mice were randomly assigned to receive a
normal chow diet (NCD, n = 6) or NCD plus subcuta-
neous injection of 0.5 mL 10% casein (NCD+Casein, n =
6) or a high fat diet (15% fat, 1.25% cholesterol, 0.5%
cholic acid) (HFD, n = 6) or HFD plus subcutaneous
injection of 0.5 mL 10% casein (HFD+Casein, n = 6).
Subcutaneous injection of 0.5 mL PBS was used as con-
trols in the NCD and HFD groups. The injections were
d o n ee v e r yo t h e rd a ya n dt h em i c ew e r ec u l l e d1 8
weeks after first injection. At termination, blood samples
were taken for cytokines and lipid assays, and tissue
samples were collected for further assessments.
Serum Analysis
Serum IL-6 (R&D, Minneapolis, USA) and serum amy-
loid A protein (SAA) concentrations were measured by
ELISA kits. Intracellular TG concentrations were deter-
mined enzymatically with commercial kits (Jiancheng,
Nanjing, China). FFA concentrations were determined
calorimetrically using commercial kits (Applygen Tech-
nologies, Beijing, China).
Observation of Lipid Accumulation
The lipid accumulation in liver, muscle and white adi-
pose tissue (epididymal fat pads) of C57BL/6J mice was
evaluated by Oil Red O staining. Briefly, samples were
fixed with 5% formalin solution and then stained with
Oil Red O for 30 minutes. Finally, the samples were
counterstained with hematoxylin for 5 minutes. Liver,
muscle and white adipose tissue were fixed, dehydrated,
infiltrated and embedded following routine method.
Results were examined by light microscopy.
Quantitative Measurement of Intracellular TG and FFA
Quantitative measurements of TG and FFA were per-
formed using commercial kits (Jiancheng, Nanjing,
China and Applygen Technologies, Beijing, China).
Briefly, samples were collected and lipids were extracted
by addition of 1 mL solvents (TG: isopropanol/chloro-
form =2/3.5, FFA: chloroform/heptane/methanol = 5/5/
1). The lipid phase was collected, dried in vacuum. The
concentration of TG and FFA were analyzed using stan-
dards and normalized by total protein from tissues.
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Page 2 of 10Glucose Tolerance Tests
Before each glucose tolerance tests, mice were starved
overnight but allowed free access to water. The glucose
tolerance was tested by the intraperitoneal injection of 2
mg D-glucose/g body weight (Sigma, St. Louis, US). The
blood glucose and serum insulin concentrations were
determined in blood, which were taken from the cut tail
tip, before and 15, 30, 60, and 120 minutes after the
administration of glucose. The glucose concentrations
were determined using an ACCU-CHEK Advantage
blood glucose meter (Roche, Mannheim, Germany).
Insulin Tolerance Tests
Before each insulin tolerance tests, mice were starved
overnight but allowed free access to water. The insulin
tolerance was tested by the intraperitoneal injection of 1
mU insulin/g body weight (Sigma, St. Louis, US). The
glucose concentrations in blood were determined using
an ACCU-CHEK Advantage blood glucose meter
(Roche, Mannheim, Germany), which were taken from
the cut tail tip, before and 15, 30, 60, and 120 minutes
after the administration of insulin.
Real-time Reverse Transcription Polymerase Chain
Reaction
Total RNA were isolated from liver, muscle and white
adipose tissue homogenates from C57BL/6J mice using
the guanidinium-phenol-chloroform method. Real-time
reverse transcription polymerase chain reaction (PCR)
was performed in a Bio-Rad Sequence Detection System
(Hercules, US) using SYBR Green dye (Applied Biosys-
tems Inc, Foster City, US) according to the manufac-
turer’s protocol. All the primers (Sigma-Genosys, UK)
were designed by Primer Express Software V2.0
(Applied Biosystems, UK) (Table 1). To normalize
expression data, 18s rRNA was used as an internal con-
trol gene.
Western blotting
Cytoplasm and nuclear proteins were extracted from
liver, muscle and white adipose tissue using commercial
kits (Pierce, Rockford, US). Sample proteins were sepa-
rated by Sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis in a Bio-Rad mini Protein apparatus, then
were transferred to NC membranes (Amersham
Bioscience, Piscatway, US). The membrane were blocked
with blocking buffer, and incubated with primary anti-
bodies (anti-SREBP1, anti-FAS, anti-ACCa , anti-ATGL,
anti-HSL and anti-b-actin from Santa Cruz biotechnol-
ogy, Inc., Santa Cruz, CA), followed by an incubation
with horseradish peroxidase-labeled secondary antibo-
dies. Finally, detection procedures were performed using
ECL Advance Western Blotting Detection kit (Amer-
sham Bioscience, Piscatway, US).
Statistical analysis
In all experiments, data were evaluated for statistical sig-
nificance using one-way ANOVA analysis of variance
followed by Q-test. A difference was considered signifi-
cant if the P value was less than 0.05.
Results
Effects of casein injection on the levels of pro-
inflammatory cytokines
We induced a chronic systemic inflammation by subcu-
taneous injection of 10% casein in C57BL/6J mice.
There were significant increases of SAA and IL-6 in
casein-injected mice fed either NCD or HFD compared
with the respective controls (Figure 1A and 1B), sug-
gesting that chronic systemic inflammation was success-
fully induced in C57BL/6J mice.
Effects of chronic systemic inflammation on ectopic lipid
deposition of C57BL/6J mice
Oil Red O staining showed that a HFD for 18 weeks
induced lipid droplet accumulation in the liver (Figure
2A III vs. 2A I), muscle (Figure 2B III vs. 2B I), and
white adipose tissues (Figure 2C III vs. 2C I) compared
with NCD group of C57BL/6J mice. Chronic systemic
inflammation induced by casein injection exacerbated
lipid accumulation in the liver from mice fed with NCD
(Figure 2A II vs. 2A I) and HFD (Figure 2A IV vs. 2A
III) as evidenced by Oil Red O staining and increased
the index of liver weight/body weight (Table 2). Chronic
systemic inflammation also increased lipid accumulation
i nt h em u s c l ef r o mm i c ef e dw i t hN C Da n dH F D ,w i t h
the appearance of massive lipid vacuoles compare to the
respective controls (Figure 2C II vs. 2C I and 2C IV vs.
2C III). Interestingly, lipid droplet accumulation has no
obvious change in while adipose tissue in the casein-
injected mice fed with NCD or HFD (Figure 2E, I-IV).
Quantitative assay further demonstrated that casein
Table 1 Mouse TaqMan Primers for Real-time PCR
Genes Mouse TaqMan Primers
SREBP1 5’-GCCCACAATGCCATTGAGA-3’ sense
5’-CAGGTCTTTGAGCTCCACAATCT-3’ antisense
FAS 5’-CCTGGATAGCATTCCGAACCT-3’sense
5’-AGCACATCTCGAAGGCTACACA-3’antisense
ACCa 5’-CGCTCAGGTCACCAAAAAGAAT-3’sense
5’-GTCCCGGCCACATAACTGAT-3’ antisense
ATGL 5’-CCTCAGGACAGCTCCACCAA-3’sense
5’-TTGAACTGGATGCTGGTGTTG-3’antisense
HSL 5’-CGAGACAGGCCTCAGTGTGA-3’sense
5’-GAATCGGCCACCGGTAAAG-3’antisense
18s rRNA 5’-TCGAGGCCCTGTAATTGGAA-3’ sense
5’-CCCTCCAATGGATCCTCGTT-3’ antisense
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greater degree in liver, and has no effect on TG and
FFA levels in white adipose tissue of C57BL/6J mice
(Figure 2B, D and 2F).
Effects of inflammation stress on lipogenesis in all tissues
and lipolysis gene expression in white adipose tissue of
C57BL/6J mice
To investigate potential mechanisms of the ectopic lipid
deposition, we evaluated the effects of chronic systemic
inflammation on the gene and protein expression of
SREBP1, FAS, ACCa in liver, muscle and white adipose
tissue of the C57BL/6J mice.
Casein injection increased the mRNA (Figure 3A, B)
and protein (Figure 4A, B) expression of SREBP1, FAS
and ACCa in liver and muscle, especially in the mice
fed with HFD, while it decreased mRNA and protein
expression of these lipogenic molecules in white adipose
tissue (Figure 3C and 4C). Interestingly, chronic sys-
temic inflammation increased mRNA (Figure 3D) and
protein (Figure 4D) expression of ATGL and HSL in
white adipose tissue.
Effects of inflammation stress on the levels of glucose,
insulin and lipid in the serum of C57BL/6J mice
Serum lipid assay demonstrated that levels of FFA in
the casein-injected mice fed with NCD or HFD were
increased compared with the respective controls (Fig-
ure 5A), suggesting that chronic systemic inflamma-
tion results in dyslipidemia in C57BL/6J mice. The
fasting glucose levels in HFD plus casein injection
group were increased compared to HFD alone group
(Figure 5B). After glucose loading, blood glucose con-
centrations in HFD plus casein injection group were
persistently higher than HFD group (Figure 5C), sug-
gesting that chronic systemic inflammation induced
glucose intolerance in C57BL/6J mice. After insulin
challenge, blood glucose levels initially were
decreased, but increased faster and higher in HFD
plus casein injection group than in HFD group after
30 min, suggesting that chronic systemic inflamma-
tion decreased insulin sensitivity in C57BL/6J mice
(Figure 5D).
Discussion
Chronic systemic inflammation plays an important role
in pathogenesis of multiple metabolic disorders, includ-
ing insulin resistance, T2DM, NAFLD, atherosclerosis,
obesity and dyslipidemia [15,16]. In this study, we use
subcutaneous injection of casein to induce chronic sys-
temic inflammation in C57BL/6J mice fed with NCD or
HFD to investigate if inflammation causes ectopic lipid
deposition in nonadipose tissues. The casein injection
model has been used in studies of atherosclerosis and
liver steatosis [17]. Comparedt oo t h e rs o l ec y t o k i n e -
treated models, casein-injection induces multiple cyto-
kines release which is more likely to mimic chronic sys-
temic inflammatory states observed in patients with
inflammatory diseases [18]. It is well-accepted that both
SAA and IL-6 are good inflammatory markers for sys-
temic and hepatic inflammatory stress. Our results
showed that casein injection significantly increased
serum levels of SAA and IL-6, suggesting that chronic
systemic inflammation was successfully induced in
C57BL/6J mice.
Normally, FFA delivered to adipose tissue is converted
to TG for storage during states of nutrient abundance.
T h e r e f o r ew h i t ea d i p o s et i s s u eh a sau n i q u ec a p a c i t yt o
store large amounts of excess lipid, while nonadipose
tissues in which FFA was utilized have a limited capacity
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Figure 1 Levels of inflammatory cytokines in the serum of
C57BL/6J mice . Mice fed with normal chow diet (NCD), NCD plus
casein injection (NCD+Casein), high fat diet (HFD) and HFD plus
casein injection (HFD+Casein) were culled 18 weeks after first
injection. The levels of SAA (A) and IL-6 (B) in the serum of C57BL/
6J mice were examined by enzyme-linked immunosorbent assay.
Results represent the mean ± SD (n = 6). * P < 0.05 versus NCD, † P
< 0.05 versus HFD.
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Page 4 of 10Figure 2 Effects of chronic systemic inflammation on lipid accumulation in liver, muscle and white adipose tissue from C57BL/6J mice
. Mice fed with normal chow diet (NCD), NCD plus casein injection (NCD+Casein), high fat diet (HFD) and HFD plus casein injection (HFD
+Casein) were culled 18 weeks after first injection. The lipid accumulation in tissues was checked by Oil Red O staining (A, C, E, original
magnification × 400) using 5-μm-thick sections and quantitative lipid measurements of tissues (B, D, F). The concentrations of TG and FFA in
tissues of C57BL/6J mice were measured as described in Materials and Methods and results represent the mean ± SD (n = 6), * P < 0.05 versus
NCD, † P < 0.05 versus HFD. (A (I-IV)) Oil Red O staining of liver. (B) The concentrations of TG (left) and FFA (right) in liver. (C (I-IV)) Oil Red O
staining of muscle. (D) The concentrations of TG (left) and FFA (right) in muscle. (E (I-IV)) Oil Red O staining of white adipose tissue. (F) The
concentrations of TG (left) and FFA (right) in white adipose tissue.
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Page 5 of 10for storage of lipids [19,20]. Adipose lipids also can be
released into circulation to form albumin/FFA com-
plexes, which allow FFA transport into nonadipose tis-
sues, such as muscle, heart, kidney and liver for b
oxidation on demand. Insulin regulates this process to
maintain FFA homeostasis in balance. As liver and mus-
cle are main insulin-sensitive and ectopic lipid accumu-
lated tissues [21], we examined the effect of chronic
systemic inflammation on lipid accumulation in these
tissues. Oil Red O staining and quantitative assays
demonstrated massive TG and FFA accumulation in the
liver and muscle in casein-injected mice fed with NCD
or HFD, suggesting a strong association between ectopic
lipid deposition and chronic systemic inflammation. We
also observed that the increases of TG and FFA con-
tents induced by inflammation are more obvious in liver
than in muscle in both NCD and HFD fed mice, which
may attribute to the preferential ability of liver in a tis-
sue-specific manner for lipogenesis. Interestingly, in the
same experimental setting, chronic systemic inflamma-
tion has no obvious effects on the lipid contents in
white adipose tissues.
Furthermore, we studied the expression of key mole-
cules involved in lipogenesis to explore potential
mechanisms of accelerated lipid accumulation induced
by casein injection. Our results showed that chronic
Table 2 Index of liver/body weights of C57BL/6J mice
Gram (n = 6) NCD NCD + Casein HFD HFD + Casein
Liver/body weights 0.04 ± 0.008 0.04 ± 0.002 0.05 ± 0.01* 0.06 ± 0.01*
* P < 0.05 versus NCD
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Figure 3 Effects of chronic systemic inflammation on the mRNA expression of lipogenesis and lipolysis in liver, muscle and white
adipose tissue of C57BL/6J mice . Mice fed with normal chow diet (NCD), NCD plus casein injection (NCD+Casein), high fat diet (HFD) and
HFD plus casein injection (HFD+Casein) were culled 18 weeks after first injection. The mRNA expression was determined by real-time PCR, 18s
rRNA served as the housekeeping gene. (A, B, C) The mRNA expression of SREBP1, FAS and ACCa in liver, muscle and white adipose tissue of
C57BL/6J mice. (D) The mRNA expression of ATGL and HSL in white adipose tissue of C57BL/6J mice. Results represent the mean ± SD (n = 6). *
P < 0.05 versus NCD, † P < 0.05 versus HFD.
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Figure 4 Effects of chronic systemic inflammation on the protein expression of lipogenesis and lipolysis in liver, muscle and white
adipose tissue of C57BL/6J mice . Mice fed with normal chow diet (NCD), NCD plus casein injection (NCD+Casein), high fat diet (HFD) and
HFD plus casein injection (HFD+Casein) were culled 18 weeks after first injection. The protein levels were determined by western blotting and b-
actin served as the internal reference. (A, B, C) The protein levels of SREBP1, FAS and ACCa in liver, muscle and white adipose tissue of C57BL/6J
mice. (D) The protein expression of ATGL and HSL in white adipose tissue of C57BL/6J mice. The histogram represents mean ± SD of the
densitometric scans for protein bands from four experiments, normalized by comparison with b-actin, and expressed as a percentage of control.
* P < 0.05 versus NCD, † P < 0.05 versus HFD.
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Page 7 of 10systemic inflammation up-regulated mRNA and protein
expression of SREBP1, ACCa and FAS in liver and mus-
cle, while decreasing the expression of these genes in
adipose tissue. These data suggest that inflammation tis-
sue-specifically switches on lipogenesis in nonadipose
tissues, especially in liver while switches off lipogenesis
in adipose tissue.
Lipid metabolism in adipose tissue is governed by
lipogenesis and lipolysis. The lipolysis of white adipose
tissue is complicated multi-step processes which per-
formed from TG to glycerol and FFA. Previous studies
discovered that enzyme ATGL seems to be responsible
for the bulk of triacylglycerol hydrolase activity in var-
ious cells and ATGL has low affinity to diacylglycerides
and monoacylglycerides. The major diacylglyceride
lipase in adipocytes is HSL. Monoacylglyceride products
of HSL are hydrolyzed by constitutively active monoa-
cylglyceride lipase. We showed that casein injection
increased both mRNA and protein expression of ATGL
and HSL in white adipose tissue, suggesting that chronic
systemic inflammation disrupts lipid metabolism by
increasing lipolysis in addition to an impaired lipogen-
esis in adipose tissue.
Ectopic lipid deposition is closely related to the devel-
opment of insulin resistance and dyslipidaemia [22]. We
evaluated serum lipids, insulin and glucose tolerance in
the mice. Our data demonstrat e dt h a tc h r o n i cs y s t e m i c
inflammation induced by casein injection exacerbated
hyperlipidaemia in C57BL/6J mice. Accordingly, in this
study, we also observed that casein injection induced
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Figure 5 Effects of chronic systemic inflammation on serum FFA concentrations, glucose and insulin resistance of C57BL/6J mice .( A )
FFA concentrations in the serum of C57BL/6J mice. (B) The fasting blood glucose concentrations in the C57BL/6J mice were measured as
described in Materials and Methods. * P < 0.05 versus NCD, † P < 0.05 versus HFD. (C) Glucose tolerance tests (glucose-stimulated blood glucose
concentrations) performed after 18 weeks of treatment in HFD group (white square, n = 6) and HFD plus casein injection mice (black triangle, n
= 6). Results of each group were normalized by their initial blood glucose (before glucose stimulation). (D) Insulin tolerance tests performed at
the end of experiments in C57BL/6J mice in HFD group (white square, n = 6) and HFD plus casein injection mice (black triangle, n = 6). Results
of each group were normalized by their initial blood glucose (before insulin stimulation). Results represent the mean ± SD (n = 6). † P < 0.05
versus HFD.
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In this context, insulin cannot effectively suppress adi-
pose tissue lipid hydrolysis which in turn increased adi-
pose tissue lipolysis.
Conclusions
This study demonstrated that chronic systemic inflam-
mation increased lipogenesis in nonadipose tissues,
while it down-regulated lipogenesis and up-regulated
lipolysis in white adipose tissues, resulting in ectopic
lipid deposition in nonadipose tissues. The deposition of
large amounts of lipids in nonadipose tissue may trigger
ER stress, oxidative stress and apoptosis, thereby causing
tissue injuries. The cytokines or chemokines released by
injured cells further exacerbate inflammation, lipid accu-
mulation and insulin resistance in a vicious cycle
[23,24]. The inflamed model established in the experi-
ments may be useful for studying the organ cross-talks
for FFA homeostasis and the mechanisms of ectopic
lipid deposition induced by chronic systemic inflamma-
tion, especially rising from chronic inflammatory dis-
eases characterized by an increased CRP level, as in
Crohn’s disease [25], autoimmune diseases [26], T2DM,
and progressive NAFLD [27].
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